{"id":"tp-28030","type":"article-newspaper","title":"JPMorgan Initiates Neurogene Coverage With $60 Price Target","author":"Enna Lee","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/investing/28030","datePublished":"2026-10-08T12:09:40.000Z","dateModified":"2026-10-08T12:09:40.000Z","language":"en","abstract":"The overweight rating implies 132% upside from the Oct. 7 close. Neurogene shares have fallen about 32% over the past three months.","section":"Investing","references":[]}